Yara Dababneh, MD1, Susheela Sreedhar, MD2, Ankita Nagirimadugu, MD1, Vivek Mendiratta, MD1, Dilip Moonka, MD1, Donard Haggins, MD1 1Henry Ford Hospital, Detroit, MI; 2Wayne State University, Detroit, MI
Introduction: We present a case of acute liver injury as a first presentation of Adult-Onset Still’s Disease (AOSD).
Case Description/Methods: A 20-year-old man presented with fever and nausea. On admission liver function tests (LFTs) were notable for ALT 81 IU/L, AST 42 IU/L, ALP 58 IU/L and total bilirubin 6.7 mg/dL. Infectious work up was notable for positive EBV IgM that was treated appropriately.
He presented again with worsening headache, fever, dark urine and petechial rash on both lower extremities. LFTs were still elevated. Patient was symptomatically managed and the elevation in LFTs was attributed to infectious etiology. Patient was discharged home with close follow up. He presented again, nine days after initial symptoms onset with worsening symptoms, jaundice and new left hip pain with lower extremity weakness. Patient had taken one pill of Metronidazole from India but denied any other drugs. LFTs were ALT 214 IU/L, AST 215 IU/L, ALP 215 IU/L and total bilirubin 6.6 mg/dL. Patient’s liver enzymes continued to rise despite discontinuing hepatotoxic medications, with ALT 186 IU/L, AST 146 IU/L, ALP 219 IU/L, total bilirubin 10.7 mg/dL and direct bilirubin 6.4 mg/dL. Therefore, a liver biopsy was ultimately performed.
Histology showed a portal inflammatory process, with acute eosinophil spill over to the liver, without hepatic necrosis. Rheumatology team was consulted due to arthralgia. The patient met the Yamaguchi criteria for AOSD. He was started on prednisone 40 mg daily, with subjective and objective improvement with down trending LFTs. Outpatient follow-up with both rheumatology and hepatology continued to show significant improvement and down-trending LFTs. He continues to be on a prolonged steroid taper over 12 weeks.
Discussion: In our case the patient met the Yamaguchi criteria which involves major and minor criteria with transaminitis included. In this case, the main challenge was to find a suitable diagnosis that fits all the symptoms. A previous case report suggested that Drug Induced Liver Injury (DILI) might be the inciting factor in AOSD activation, which might be proposed in our case as well. It was reported that liver involvement in AOSD can be attributed to its association with Macrophage Activation Syndrome (MAS). Treatment mainly focuses on treating AOSD itself with systemic steroid therapy. In conclusion, acute liver injury is being increasingly reported in literature and this case supports acute liver injury in association with AOSD which can be aggravated by DILI or MAS.
Disclosures:
Yara Dababneh indicated no relevant financial relationships.
Susheela Sreedhar indicated no relevant financial relationships.
Ankita Nagirimadugu indicated no relevant financial relationships.
Vivek Mendiratta indicated no relevant financial relationships.
Dilip Moonka indicated no relevant financial relationships.
Donard Haggins indicated no relevant financial relationships.
Yara Dababneh, MD1, Susheela Sreedhar, MD2, Ankita Nagirimadugu, MD1, Vivek Mendiratta, MD1, Dilip Moonka, MD1, Donard Haggins, MD1. B0567 - Acute Liver Injury as Initial Presentation of Adult Onset Still’s Disease, ACG 2022 Annual Scientific Meeting Abstracts. Charlotte, NC: American College of Gastroenterology.